Urgent Warning: Drug-Resistant Malaria Threatens East Africa
A recent study in the journal Science highlights alarming mutations in malaria parasites, indicating rising drug resistance in East Africa. Over 10% of malaria cases in countries like Ethiopia and Uganda show resistance to artemisinin, threatening the effectiveness of Artemisinin Combination Therapies (ACTs). With malaria claiming over 1,000 children’s lives daily in Africa, urgent action is needed from policymakers and global organizations to combat this growing public health crisis.
Alarm Over Rising Drug-Resistant Malaria in Africa
A recent study published in Science warns of the alarming rise of drug-resistant malaria in Africa, threatening millions of lives. Researchers found artemisinin resistance in over 10% of malaria cases in East Africa, raising concerns about the effectiveness of Artemisinin Combination Therapies (ACTs). Experts call for urgent action and increased investment in malaria research to combat this emerging health crisis.
New Insights into Drug-Resistant Prostate Cancer
New research from the University of Eastern Finland sheds light on combatting drug-resistant prostate cancer by targeting the glucocorticoid receptor. Limiting the activity of coregulator proteins could prevent the development of drug resistance, offering potential new treatment strategies for this challenging cancer type.